Search research articles
Contact Us
Filters
Showing results (301-310 of 539) with videos related to
Page
of 54
Sort By:
Movement Disorders Clinical Practice
|
January 19, 2026
MRI Assessment of Nigrosome in Parkinson's Disease: Is it Currently a Valuable Tool in Clinical Practice?
Agustina Ruiz Yanzi, José Á Pineda-Pardo, Elena Natera-Villalba, et al.
Revista Clinica Espanola
|
October 15, 1981
[Acute polyradiculoneuritis and amyotrophic neuralgia in Addison's disease]
J F Martí-Massó, J A Obeso, E de la Puente, et al.
Neurologia (Barcelona, Spain)
|
October 1, 1991
[Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences]
M R Luquin, J A Obeso, M T Herrero, et al.
Handbook of Clinical Neurology
|
September 24, 2008
Levodopa-induced dyskinesias in Parkinson's disease
Jose A Obeso, Marcelo Merello, Maria C Rodríguez-Oroz, et al.
Lancet (London, England)
|
June 24, 2014
The expanding universe of disorders of the basal ganglia
Jose A Obeso, Maria C Rodriguez-Oroz, Maria Stamelou, et al.
Neuropathology and Applied Neurobiology
|
March 11, 2022
Neuron types in the primate striatum: Stereological analysis of projection neurons and interneurons in control and parkinsonian monkeys
Natalia López-González Del Rey, Inés Trigo-Damas, José A Obeso, et al.
Clinical Neuropharmacology
|
October 12, 1999
Modification of dopamine D2 receptor activity by pergolide in Parkinson's disease: an in vivo study by PET
G Linazasoro, J A Obeso, J C Gómez, et al.
Annals of Neurology
|
December 1, 1978
Treatment with hemiballism with reserpine
J A Obeso, J F Marti-Masso, W Astudillo, et al.
Brain Research
|
July 10, 1992
Chronic MPTP treatment reduces substance P and met-enkephalin content in the basal ganglia of the marmoset
I Pérez-Otaño, M T Herrero, M R Luquin, et al.
Clinical Neuropharmacology
|
February 1, 1992
Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's disease
F Grandas, S T Gancher, M Rodriguez, et al.
Page
of 54
Search research articles
Search
Showing results (301-310 of 539) with videos related to
Sort By:
Page
of 54
Movement Disorders Clinical Practice
|
January 19, 2026
MRI Assessment of Nigrosome in Parkinson's Disease: Is it Currently a Valuable Tool in Clinical Practice?
Agustina Ruiz Yanzi, José Á Pineda-Pardo, Elena Natera-Villalba, et al.
Revista Clinica Espanola
|
October 15, 1981
[Acute polyradiculoneuritis and amyotrophic neuralgia in Addison's disease]
J F Martí-Massó, J A Obeso, E de la Puente, et al.
Neurologia (Barcelona, Spain)
|
October 1, 1991
[Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences]
M R Luquin, J A Obeso, M T Herrero, et al.
Handbook of Clinical Neurology
|
September 24, 2008
Levodopa-induced dyskinesias in Parkinson's disease
Jose A Obeso, Marcelo Merello, Maria C Rodríguez-Oroz, et al.
Lancet (London, England)
|
June 24, 2014
The expanding universe of disorders of the basal ganglia
Jose A Obeso, Maria C Rodriguez-Oroz, Maria Stamelou, et al.
Neuropathology and Applied Neurobiology
|
March 11, 2022
Neuron types in the primate striatum: Stereological analysis of projection neurons and interneurons in control and parkinsonian monkeys
Natalia López-González Del Rey, Inés Trigo-Damas, José A Obeso, et al.
Clinical Neuropharmacology
|
October 12, 1999
Modification of dopamine D2 receptor activity by pergolide in Parkinson's disease: an in vivo study by PET
G Linazasoro, J A Obeso, J C Gómez, et al.
Annals of Neurology
|
December 1, 1978
Treatment with hemiballism with reserpine
J A Obeso, J F Marti-Masso, W Astudillo, et al.
Brain Research
|
July 10, 1992
Chronic MPTP treatment reduces substance P and met-enkephalin content in the basal ganglia of the marmoset
I Pérez-Otaño, M T Herrero, M R Luquin, et al.
Clinical Neuropharmacology
|
February 1, 1992
Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's disease
F Grandas, S T Gancher, M Rodriguez, et al.
Page
of 54